The advertisement promotes Boston Scientific's minimally invasive TCAR therapy, highlighting its potential to reduce stroke risk.
Creative Information
| CID: | b73c4ef9-49e5-41a8-8353-c1a3c53fa0e9 |
| CRID: | 2_206_490157 |
| Domain: | bostonscientific.com |
| Seat: | BSW |
| Size: | 320x50 |
| Bid: | $1.34 |
| Timestamp: | 10/30/2025, 2:15:48 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 10/31/2025, 1:14:01 AM | 5.66s | |
| adomain_analysis | success | 10/31/2025, 1:14:43 AM | 3.02s | |
| adomain_capture | success | 10/31/2025, 1:14:05 AM | 0.22s | |
| ad_render | success | 10/30/2025, 2:55:43 PM | 16.35s | |
| brand_mapping | success | 10/31/2025, 12:52:17 AM | 0.10s | |
Analysis Results
Ad Format: banner
Brands: Boston Scientific
| Size: | 320x50 | ||||||||||||||||||||||
| Data Transferred: | 712.80 KB | ||||||||||||||||||||||
| Render Time: | 7.66 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Total Ad Size: | 731.97 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain
Ad Preview
Raw Ad Markup
<ins class='dcmads' style='display:inline-block;width:320px;height:50px' data-dcm-placement='N1991638.2055741ADTHEORANT/B33614802.421066112' data-dcm-rendering-mode='script' data-dcm-https-only data-dcm-keywords='742ceb71-b411-11f0-8310-1299872f8eb1' data-dcm-click-tracker='https%3A%2F%2Frtb.adentifi.com%2FClicks%3FcrId%3D490157%3BsId%3D772807%3BlId%3D103491%3BcId%3D19716%3BadExchange%3DBidSwitch%3Baction%3Dclick%3BadId%3D742ceb71-b411-11f0-8310-1299872f8eb1%3BadThdId%3Db581f40fb08610f38b8b77c7c25ba0c0%3BengineId%3Di-088227d5b9e94df4e%3BdIp%3DOTkuMTI0LjE5MC4xMzU%3BdIpv6%3D%3BadThdIdCode%3DWEB_MD5_V4%3BdealId%3D0%3BgeoId%3D35559%3BinventoryId%3D259726%3BrtdmIndicator%3D1%3Btimestamp%3D1761664750%3Blat%3DMzAuMTc%3Blong%3DLTgxLjQ%3Bdma%3DNTYx%3BstateCode%3D%3Bzip%3DMzIwODI%3Bbsc%3D${CLICK_URL_ENC}%3Bredir%3D' data-dcm-resettable-device-id='' data-dcm-api-frameworks='[APIFRAMEWORKS]' data-dcm-omid-partner='[OMIDPARTNER]' data-dcm-ltd='false' data-dcm-app-id=''> <script src='https://www.googletagservices.com/dcm/dcmads.js'></script></ins><img src='https://rtb.adentifi.com/Imps?impId=1;adId=742ceb71-b411-11f0-8310-1299872f8eb1;lId=103491;sId=772807;cId=19716;crId=490157;adThdId=b581f40fb08610f38b8b77c7c25ba0c0;adExchange=BidSwitch;engineId=i-088227d5b9e94df4e;dealId=0;geoId=35559;inventoryId=259726;rtdmIndicator=1;timestamp=1761664750;property=merriam-webster.com;dIp=OTkuMTI0LjE5MC4xMzU;dIpv6=;adThdIdCode=WEB_MD5_V4;thirdPartyIdType=1;npiKey=5307816007775420297;hhId=452595015;cuid=cuid_e7ff4b01-9a00-11ef-9829-12f7f0962d75' style='display:none; width:0px; height:0px;' /><script src="https://tags.bkrtx.com/js/bk-coretag.js"></script><script>bk_addPageCtx("id","cuid_e7ff4b01-9a00-11ef-9829-12f7f0962d75");bk_allow_multiple_calls = true;bk_use_multiple_iframes = true;bk_send_statid_payload = true;bk_use_image = true;bk_callback = true;bk_doJSTag(18840, 4);</script><img src='https://sb.scorecardresearch.com/p?c1=9&c2=16077523&c3=2&cs_xi=cuid_e7ff4b01-9a00-11ef-9829-12f7f0962d75&rn=742ceb71-b411-11f0-8310-1299872f8eb1' height='0' width='0' /><span id="te-clearads-js-adtheorent01cont490157"><script type="text/javascript" src="//choices.truste.com/ca?pid=adtheorent01&aid=adtheorent01&cid=19716&c=adtheorent01cont490157&w=320&h=50&js=pmw0&plc=tr&uid=b581f40fb08610f38b8b77c7c25ba0c0"></script></span><img src="https://us-east-sync.bidswitch.net/sync?ssp=kargo&dsp_id=206&imp=1" alt=" " style="display:none"/>Creatives
